 | • レポートコード：B-GIR08C1447 • 出版社/出版日：GlobalInfoResearch / 2019年8月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、137ページ • 納品方法：Eメール • 産業分類：Medical Care |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは、先天性心疾患治療の世界市場について調べ、まとめました。種類別セグメントは、薬、外科療法等、用途別セグメントは、慢性心不全、心筋梗塞、術後低血圧、気管支喘息、喘息性気管支炎、気腫、その他等に区分しました。先天性心疾患治療の世界市場概観、企業動向、企業別先天性心疾患治療シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・先天性心疾患治療の市場概観 ・先天性心疾患治療の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・先天性心疾患治療の企業別販売動向、市場シェア、市場集中度、競争動向 ・先天性心疾患治療の世界市場規模 ・先天性心疾患治療の北米市場分析（アメリカ、カナダ、メキシコ等） ・先天性心疾患治療のアメリカ市場規模推移 ・先天性心疾患治療のカナダ市場規模推移 ・先天性心疾患治療のメキシコ市場規模推移 ・先天性心疾患治療のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等） ・先天性心疾患治療のドイツ市場規模推移 ・先天性心疾患治療のイギリス市場規模推移 ・先天性心疾患治療のロシア市場規模推移 ・先天性心疾患治療のアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等） ・先天性心疾患治療の日本市場規模推移 ・先天性心疾患治療の中国市場規模推移 ・先天性心疾患治療の韓国市場規模推移 ・先天性心疾患治療のインド市場規模推移 ・先天性心疾患治療の東南アジア市場規模推移 ・先天性心疾患治療の南米市場分析（ブラジル、アルゼンチン等） ・先天性心疾患治療の中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等） ・先天性心疾患治療の種類別分析/販売量、売上、市場シェア（薬、外科療法） ・先天性心疾患治療の用途別分析/市場規模（慢性心不全、心筋梗塞、術後低血圧、気管支喘息、喘息性気管支炎、気腫、その他） ・先天性心疾患治療の市場予測2019年-2024年（地域別予測、種類別予測、用途別予測） ・先天性心疾患治療の販売チャネル・代理店・貿易業者・ディーラー分析 |
A congenital heart defect (CHD), also known as a congenital heart anomaly or congenital heart disease, is a problem in the structure of the heart that is present at birth. Signs and symptoms depend on the specific type of problem. Symptoms can vary from none to life-threatening. When present they may include rapid breathing, bluish skin, poor weight gain, and feeling tired. It does not cause chest pain. Most congenital heart problems do not occur with other diseases. Complications that can result from heart defects include heart failure.
Scope of the Report:
The global Congenital Heart Disease Treatment market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Congenital Heart Disease Treatment.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Congenital Heart Disease Treatment market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Congenital Heart Disease Treatment market by product type and applications/end industries.
Market Segment by Companies, this report covers
Pfizer
Novartis
Abbott Laboratories
Roche
GSK
Sanofi
Johnson & Johnson
Medtronic
BD
Boston Scientific
Merck
Eli Lilly
Mylan
Sun Pharmaceutical
AstraZeneca
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Medication
Surgical Therapy
Market Segment by Applications, can be divided into
Hospitals and Clinics
Diagnostic Centers
Table of Contents
1 Congenital Heart Disease Treatment Market Overview
1.1 Product Overview and Scope of Congenital Heart Disease Treatment
1.2 Classification of Congenital Heart Disease Treatment by Types
1.2.1 Global Congenital Heart Disease Treatment Revenue Comparison by Types (2019-2024)
1.2.2 Global Congenital Heart Disease Treatment Revenue Market Share by Types in 2018
1.2.3 Medication
1.2.4 Surgical Therapy
1.3 Global Congenital Heart Disease Treatment Market by Application
1.3.1 Global Congenital Heart Disease Treatment Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 Hospitals and Clinics
1.3.3 Diagnostic Centers
1.4 Global Congenital Heart Disease Treatment Market by Regions
1.4.1 Global Congenital Heart Disease Treatment Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) Congenital Heart Disease Treatment Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Congenital Heart Disease Treatment Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Congenital Heart Disease Treatment Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) Congenital Heart Disease Treatment Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Congenital Heart Disease Treatment Status and Prospect (2014-2024)
1.5 Global Market Size of Congenital Heart Disease Treatment (2014-2024)
2 Manufacturers Profiles
2.1 Pfizer
2.1.1 Business Overview
2.1.2 Congenital Heart Disease Treatment Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Pfizer Congenital Heart Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.2 Novartis
2.2.1 Business Overview
2.2.2 Congenital Heart Disease Treatment Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Novartis Congenital Heart Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.3 Abbott Laboratories
2.3.1 Business Overview
2.3.2 Congenital Heart Disease Treatment Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Abbott Laboratories Congenital Heart Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.4 Roche
2.4.1 Business Overview
2.4.2 Congenital Heart Disease Treatment Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Roche Congenital Heart Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.5 GSK
2.5.1 Business Overview
2.5.2 Congenital Heart Disease Treatment Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 GSK Congenital Heart Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.6 Sanofi
2.6.1 Business Overview
2.6.2 Congenital Heart Disease Treatment Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Sanofi Congenital Heart Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.7 Johnson & Johnson
2.7.1 Business Overview
2.7.2 Congenital Heart Disease Treatment Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Johnson & Johnson Congenital Heart Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.8 Medtronic
2.8.1 Business Overview
2.8.2 Congenital Heart Disease Treatment Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Medtronic Congenital Heart Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.9 BD
2.9.1 Business Overview
2.9.2 Congenital Heart Disease Treatment Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 BD Congenital Heart Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.10 Boston Scientific
2.10.1 Business Overview
2.10.2 Congenital Heart Disease Treatment Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Boston Scientific Congenital Heart Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.11 Merck
2.11.1 Business Overview
2.11.2 Congenital Heart Disease Treatment Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Merck Congenital Heart Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.12 Eli Lilly
2.12.1 Business Overview
2.12.2 Congenital Heart Disease Treatment Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Eli Lilly Congenital Heart Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.13 Mylan
2.13.1 Business Overview
2.13.2 Congenital Heart Disease Treatment Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 Mylan Congenital Heart Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.14 Sun Pharmaceutical
2.14.1 Business Overview
2.14.2 Congenital Heart Disease Treatment Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 Sun Pharmaceutical Congenital Heart Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.15 AstraZeneca
2.15.1 Business Overview
2.15.2 Congenital Heart Disease Treatment Type and Applications
2.15.2.1 Product A
2.15.2.2 Product B
2.15.3 AstraZeneca Congenital Heart Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
3 Global Congenital Heart Disease Treatment Market Competition, by Players
3.1 Global Congenital Heart Disease Treatment Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Congenital Heart Disease Treatment Players Market Share
3.2.2 Top 10 Congenital Heart Disease Treatment Players Market Share
3.3 Market Competition Trend
4 Global Congenital Heart Disease Treatment Market Size by Regions
4.1 Global Congenital Heart Disease Treatment Revenue and Market Share by Regions
4.2 North America Congenital Heart Disease Treatment Revenue and Growth Rate (2014-2019)
4.3 Europe Congenital Heart Disease Treatment Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific Congenital Heart Disease Treatment Revenue and Growth Rate (2014-2019)
4.5 South America Congenital Heart Disease Treatment Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa Congenital Heart Disease Treatment Revenue and Growth Rate (2014-2019)
5 North America Congenital Heart Disease Treatment Revenue by Countries
5.1 North America Congenital Heart Disease Treatment Revenue by Countries (2014-2019)
5.2 USA Congenital Heart Disease Treatment Revenue and Growth Rate (2014-2019)
5.3 Canada Congenital Heart Disease Treatment Revenue and Growth Rate (2014-2019)
5.4 Mexico Congenital Heart Disease Treatment Revenue and Growth Rate (2014-2019)
6 Europe Congenital Heart Disease Treatment Revenue by Countries
6.1 Europe Congenital Heart Disease Treatment Revenue by Countries (2014-2019)
6.2 Germany Congenital Heart Disease Treatment Revenue and Growth Rate (2014-2019)
6.3 UK Congenital Heart Disease Treatment Revenue and Growth Rate (2014-2019)
6.4 France Congenital Heart Disease Treatment Revenue and Growth Rate (2014-2019)
6.5 Russia Congenital Heart Disease Treatment Revenue and Growth Rate (2014-2019)
6.6 Italy Congenital Heart Disease Treatment Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Congenital Heart Disease Treatment Revenue by Countries
7.1 Asia-Pacific Congenital Heart Disease Treatment Revenue by Countries (2014-2019)
7.2 China Congenital Heart Disease Treatment Revenue and Growth Rate (2014-2019)
7.3 Japan Congenital Heart Disease Treatment Revenue and Growth Rate (2014-2019)
7.4 Korea Congenital Heart Disease Treatment Revenue and Growth Rate (2014-2019)
7.5 India Congenital Heart Disease Treatment Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia Congenital Heart Disease Treatment Revenue and Growth Rate (2014-2019)
8 South America Congenital Heart Disease Treatment Revenue by Countries
8.1 South America Congenital Heart Disease Treatment Revenue by Countries (2014-2019)
8.2 Brazil Congenital Heart Disease Treatment Revenue and Growth Rate (2014-2019)
8.3 Argentina Congenital Heart Disease Treatment Revenue and Growth Rate (2014-2019)
8.4 Colombia Congenital Heart Disease Treatment Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Congenital Heart Disease Treatment by Countries
9.1 Middle East and Africa Congenital Heart Disease Treatment Revenue by Countries (2014-2019)
9.2 Saudi Arabia Congenital Heart Disease Treatment Revenue and Growth Rate (2014-2019)
9.3 UAE Congenital Heart Disease Treatment Revenue and Growth Rate (2014-2019)
9.4 Egypt Congenital Heart Disease Treatment Revenue and Growth Rate (2014-2019)
9.5 Nigeria Congenital Heart Disease Treatment Revenue and Growth Rate (2014-2019)
9.6 South Africa Congenital Heart Disease Treatment Revenue and Growth Rate (2014-2019)
10 Global Congenital Heart Disease Treatment Market Segment by Type
10.1 Global Congenital Heart Disease Treatment Revenue and Market Share by Type (2014-2019)
10.2 Global Congenital Heart Disease Treatment Market Forecast by Type (2019-2024)
10.3 Medication Revenue Growth Rate (2014-2024)
10.4 Surgical Therapy Revenue Growth Rate (2014-2024)
11 Global Congenital Heart Disease Treatment Market Segment by Application
11.1 Global Congenital Heart Disease Treatment Revenue Market Share by Application (2014-2019)
11.2 Congenital Heart Disease Treatment Market Forecast by Application (2019-2024)
11.3 Hospitals and Clinics Revenue Growth (2014-2019)
11.4 Diagnostic Centers Revenue Growth (2014-2019)
12 Global Congenital Heart Disease Treatment Market Size Forecast (2019-2024)
12.1 Global Congenital Heart Disease Treatment Market Size Forecast (2019-2024)
12.2 Global Congenital Heart Disease Treatment Market Forecast by Regions (2019-2024)
12.3 North America Congenital Heart Disease Treatment Revenue Market Forecast (2019-2024)
12.4 Europe Congenital Heart Disease Treatment Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific Congenital Heart Disease Treatment Revenue Market Forecast (2019-2024)
12.6 South America Congenital Heart Disease Treatment Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa Congenital Heart Disease Treatment Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
Figure Congenital Heart Disease Treatment Picture
Table Product Specifications of Congenital Heart Disease Treatment
Table Global Congenital Heart Disease Treatment and Revenue (Million USD) Market Split by Product Type
Figure Global Congenital Heart Disease Treatment Revenue Market Share by Types in 2018
Figure Medication Picture
Figure Surgical Therapy Picture
Table Global Congenital Heart Disease Treatment Revenue (Million USD) by Application (2014-2024)
Figure Congenital Heart Disease Treatment Revenue Market Share by Applications in 2018
Figure Hospitals and Clinics Picture
Figure Diagnostic Centers Picture
Table Global Market Congenital Heart Disease Treatment Revenue (Million USD) Comparison by Regions 2014-2024
Figure North America Congenital Heart Disease Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Figure Europe Congenital Heart Disease Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Figure Asia-Pacific Congenital Heart Disease Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Figure South America Congenital Heart Disease Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Figure Middle East and Africa Congenital Heart Disease Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Figure Global Congenital Heart Disease Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer Congenital Heart Disease Treatment Type and Applications
Table Pfizer Congenital Heart Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Novartis Basic Information, Manufacturing Base and Competitors
Table Novartis Congenital Heart Disease Treatment Type and Applications
Table Novartis Congenital Heart Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Abbott Laboratories Basic Information, Manufacturing Base and Competitors
Table Abbott Laboratories Congenital Heart Disease Treatment Type and Applications
Table Abbott Laboratories Congenital Heart Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Roche Basic Information, Manufacturing Base and Competitors
Table Roche Congenital Heart Disease Treatment Type and Applications
Table Roche Congenital Heart Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table GSK Basic Information, Manufacturing Base and Competitors
Table GSK Congenital Heart Disease Treatment Type and Applications
Table GSK Congenital Heart Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Sanofi Basic Information, Manufacturing Base and Competitors
Table Sanofi Congenital Heart Disease Treatment Type and Applications
Table Sanofi Congenital Heart Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table Johnson & Johnson Congenital Heart Disease Treatment Type and Applications
Table Johnson & Johnson Congenital Heart Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Medtronic Basic Information, Manufacturing Base and Competitors
Table Medtronic Congenital Heart Disease Treatment Type and Applications
Table Medtronic Congenital Heart Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table BD Basic Information, Manufacturing Base and Competitors
Table BD Congenital Heart Disease Treatment Type and Applications
Table BD Congenital Heart Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Boston Scientific Basic Information, Manufacturing Base and Competitors
Table Boston Scientific Congenital Heart Disease Treatment Type and Applications
Table Boston Scientific Congenital Heart Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Merck Basic Information, Manufacturing Base and Competitors
Table Merck Congenital Heart Disease Treatment Type and Applications
Table Merck Congenital Heart Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Eli Lilly Basic Information, Manufacturing Base and Competitors
Table Eli Lilly Congenital Heart Disease Treatment Type and Applications
Table Eli Lilly Congenital Heart Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Mylan Basic Information, Manufacturing Base and Competitors
Table Mylan Congenital Heart Disease Treatment Type and Applications
Table Mylan Congenital Heart Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Sun Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table Sun Pharmaceutical Congenital Heart Disease Treatment Type and Applications
Table Sun Pharmaceutical Congenital Heart Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table AstraZeneca Basic Information, Manufacturing Base and Competitors
Table AstraZeneca Congenital Heart Disease Treatment Type and Applications
Table AstraZeneca Congenital Heart Disease Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Global Congenital Heart Disease Treatment Revenue (Million USD) by Players (2014-2019)
Table Global Congenital Heart Disease Treatment Revenue Share by Players (2014-2019)
Figure Global Congenital Heart Disease Treatment Revenue Share by Players in 2017
Figure Global Congenital Heart Disease Treatment Revenue Share by Players in 2018
Figure Global Top 5 Players Congenital Heart Disease Treatment Revenue Market Share in 2018
Figure Global Top 10 Players Congenital Heart Disease Treatment Revenue Market Share in 2018
Figure Global Congenital Heart Disease Treatment Revenue (Million USD) and Growth Rate (%) (2014-2019)
Table Global Congenital Heart Disease Treatment Revenue (Million USD) by Regions (2014-2019)
Table Global Congenital Heart Disease Treatment Revenue Market Share by Regions (2014-2019)
Figure Global Congenital Heart Disease Treatment Revenue Market Share by Regions (2014-2019)
Figure Global Congenital Heart Disease Treatment Revenue Market Share by Regions in 2018
Figure North America Congenital Heart Disease Treatment Revenue and Growth Rate (2014-2019)
Figure Europe Congenital Heart Disease Treatment Revenue and Growth Rate (2014-2019)
Figure Asia-Pacific Congenital Heart Disease Treatment Revenue and Growth Rate (2014-2019)
Figure South America Congenital Heart Disease Treatment Revenue and Growth Rate (2014-2019)
Figure Middle East and Africa Congenital Heart Disease Treatment Revenue and Growth Rate (2014-2019)
Table North America Congenital Heart Disease Treatment Revenue by Countries (2014-2019)
Table North America Congenital Heart Disease Treatment Revenue Market Share by Countries (2014-2019)
Figure North America Congenital Heart Disease Treatment Revenue Market Share by Countries (2014-2019)
Figure North America Congenital Heart Disease Treatment Revenue Market Share by Countries in 2018
Figure USA Congenital Heart Disease Treatment Revenue and Growth Rate (2014-2019)
Figure Canada Congenital Heart Disease Treatment Revenue and Growth Rate (2014-2019)
Figure Mexico Congenital Heart Disease Treatment Revenue and Growth Rate (2014-2019)
Table Europe Congenital Heart Disease Treatment Revenue (Million USD) by Countries (2014-2019)
Figure Europe Congenital Heart Disease Treatment Revenue Market Share by Countries (2014-2019)
Figure Europe Congenital Heart Disease Treatment Revenue Market Share by Countries in 2018
Figure Germany Congenital Heart Disease Treatment Revenue and Growth Rate (2014-2019)
Figure UK Congenital Heart Disease Treatment Revenue and Growth Rate (2014-2019)
Figure France Congenital Heart Disease Treatment Revenue and Growth Rate (2014-2019)
Figure Russia Congenital Heart Disease Treatment Revenue and Growth Rate (2014-2019)
Figure Italy Congenital Heart Disease Treatment Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Congenital Heart Disease Treatment Revenue (Million USD) by Countries (2014-2019)
Figure Asia-Pacific Congenital Heart Disease Treatment Revenue Market Share by Countries (2014-2019)
Figure Asia-Pacific Congenital Heart Disease Treatment Revenue Market Share by Countries in 2018
Figure China Congenital Heart Disease Treatment Revenue and Growth Rate (2014-2019)
Figure Japan Congenital Heart Disease Treatment Revenue and Growth Rate (2014-2019)
Figure Korea Congenital Heart Disease Treatment Revenue and Growth Rate (2014-2019)
Figure India Congenital Heart Disease Treatment Revenue and Growth Rate (2014-2019)
Figure Southeast Asia Congenital Heart Disease Treatment Revenue and Growth Rate (2014-2019)
Table South America Congenital Heart Disease Treatment Revenue by Countries (2014-2019)
Table South America Congenital Heart Disease Treatment Revenue Market Share by Countries (2014-2019)
Figure South America Congenital Heart Disease Treatment Revenue Market Share by Countries (2014-2019)
Figure South America Congenital Heart Disease Treatment Revenue Market Share by Countries in 2018
Figure Brazil Congenital Heart Disease Treatment Revenue and Growth Rate (2014-2019)
Figure Argentina Congenital Heart Disease Treatment Revenue and Growth Rate (2014-2019)
Figure Colombia Congenital Heart Disease Treatment Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Congenital Heart Disease Treatment Revenue (Million USD) by Countries (2014-2019)
Table Middle East and Africa Congenital Heart Disease Treatment Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Congenital Heart Disease Treatment Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Congenital Heart Disease Treatment Revenue Market Share by Countries in 2018
Figure Saudi Arabia Congenital Heart Disease Treatment Revenue and Growth Rate (2014-2019)
Figure UAE Congenital Heart Disease Treatment Revenue and Growth Rate (2014-2019)
Figure Egypt Congenital Heart Disease Treatment Revenue and Growth Rate (2014-2019)
Figure Nigeria Congenital Heart Disease Treatment Revenue and Growth Rate (2014-2019)
Figure South Africa Congenital Heart Disease Treatment Revenue and Growth Rate (2014-2019)
Table Global Congenital Heart Disease Treatment Revenue (Million USD) by Type (2014-2019)
Table Global Congenital Heart Disease Treatment Revenue Share by Type (2014-2019)
Figure Global Congenital Heart Disease Treatment Revenue Share by Type (2014-2019)
Figure Global Congenital Heart Disease Treatment Revenue Share by Type in 2018
Table Global Congenital Heart Disease Treatment Revenue Forecast by Type (2019-2024)
Figure Global Congenital Heart Disease Treatment Market Share Forecast by Type (2019-2024)
Figure Global Medication Revenue Growth Rate (2014-2019)
Figure Global Surgical Therapy Revenue Growth Rate (2014-2019)
Table Global Congenital Heart Disease Treatment Revenue by Application (2014-2019)
Table Global Congenital Heart Disease Treatment Revenue Share by Application (2014-2019)
Figure Global Congenital Heart Disease Treatment Revenue Share by Application (2014-2019)
Figure Global Congenital Heart Disease Treatment Revenue Share by Application in 2018
Table Global Congenital Heart Disease Treatment Revenue Forecast by Application (2019-2024)
Figure Global Congenital Heart Disease Treatment Market Share Forecast by Application (2019-2024)
Figure Global Hospitals and Clinics Revenue Growth Rate (2014-2019)
Figure Global Diagnostic Centers Revenue Growth Rate (2014-2019)
Figure Global Congenital Heart Disease Treatment Revenue (Million USD) and Growth Rate Forecast (2019-2024)
Table Global Congenital Heart Disease Treatment Revenue (Million USD) Forecast by Regions (2019-2024)
Figure Global Congenital Heart Disease Treatment Revenue Market Share Forecast by Regions (2019-2024)
Figure North America Congenital Heart Disease Treatment Revenue Market Forecast (2019-2024)
Figure Europe Congenital Heart Disease Treatment Revenue Market Forecast (2019-2024)
Figure Asia-Pacific Congenital Heart Disease Treatment Revenue Market Forecast (2019-2024)
Figure South America Congenital Heart Disease Treatment Revenue Market Forecast (2019-2024)
Figure Middle East and Africa Congenital Heart Disease Treatment Revenue Market Forecast (2019-2024)
世界の先天性心疾患市場：市場規模・現状・予測 A congenital heart disease is a problem in the structure of the heart that is present at birth.The factors driving the growth of the global congenital heart disease market are rising prevalence of congenital heart disease and rise in adoption of minimally invasive procedures. Further, large number o…- 世界の炎症性心疾患市場：市場規模・現状・予測 Inflammatory heart disease is mainly caused by various infectious agents which includes viruses, bacteria, fungi and parasites. These infectious agents came into contact with human body via various toxic materials from the environment.Changing lifestyle resulting in higher prevalence of viral and fu…
- 世界のリウマチ性心疾患市場：市場規模・現状・予測 Rheumatic heart disease is a complication ofrheumatic fever in which the heart valves are damaged.Increasing environmental pollution resulting in higher prevalence of viral and fungal infection is one of the major factor motivating the growth of this market. In addition, increasing healthcare expend…
- 世界の転移性骨疾患の治療市場：市場規模・現状・予測 Metastatic bone disease can be quite agonizing to patients, both emotionally and financially, when they discover that their cancer has reached an advanced stage, thereby diminishing their chance of survival and adding to the treatment costs. In 2018, the global Medication Treatment of Metastatic Bon…
- 世界のRefsum病治療市場：市場規模・現状・予測 Refsum disease, also known as classic or adult Refsum disease, heredopathia atactica polyneuritiformis, phytanic acid oxidase deficiency and phytanic acid storage disease, is an autosomal recessive neurological disease that results in the over-accumulation of phytanic acid in cells and tissues.The A…